Cargando…
OR13-001 Loss-of-function mutations in CECR1, encoding adenosine deaminase 2 (ADA2), cause recurrent fevers and early onset strokes
Autores principales: | Zhou, Q, Zavialov, A, Chae, J, Hershfield, M, Sood, R, Burgess, S, Chin, D, Gadina, M, Goldbach-Mansky, R, Ombrello, A, Stone, D, Aksentijevich, I, Kastner, D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3953048/ http://dx.doi.org/10.1186/1546-0096-11-S1-A263 |
Ejemplares similares
-
The deficiency of adenosine deaminase type 2-results of therapeutic intervention
por: Ombrello, A, et al.
Publicado: (2015) -
ELISA based assays to measure adenosine deaminases concentration in serum and saliva for the diagnosis of ADA2 deficiency and cancer
por: Luo, Wenwen, et al.
Publicado: (2022) -
OR13-002 Recessive mutations in CECR1, encoding adenosine deaminase 2 (ADA2), cause systemic and cutaneous polyarteritis nodosa (PAN)
por: Levy-Lahad, E, et al.
Publicado: (2013) -
Clinical follow-up on a cohort of patients with deficiency of adenosine deaminase 2 (DADA2)
por: Barron, K, et al.
Publicado: (2015) -
Update on CECR1 molecular diagnostics: new mutations in the deficiency of ADA2 (DADA2) and the North American polyarteritis nodosa (PAN) cohort
por: Stoffels, M, et al.
Publicado: (2015)